Prevalence and outcome of latent tuberculosis in patients receiving ixekizumab: integrated safety analysis from 11 clinical trials of patients with plaque psoriasis. (11th March 2019) - Romiti, R.; Valenzuela, F.; Chouela, E.N.; Xu, W.; Pangallo, B.; Moriarty, S.R.; Gürbüz, S.; Riedl, E.